Newsletter

317450 - Myungin Pharm

317450 Summary
Biopharma
Stock Price & Overview
₩44,650 +0 (+0.00%) Close · Sep 4, 2026 KST
KOSPI | ₩KRW | Close: ₩44,650  ≈ US$32  ·  Market cap ₩0.7tn (≈ $466m)
What kstock news is. Short items on what actually happened — a filing, an order, a buyback, a result — written from the Korean filing or the Korean press for people who cannot read either. Each one puts the event against a figure from this company's own statements. No view, no rating; that is what analysis is for.

317450 News

All kstock news »

No news written yet.

0 items. Written from DART filings and Korean press reports; every item lists its source.

Similar to 317450

SymbolLast Price
476830Rznomics, Inc.₩28,200
+6.8%
003850Boryung Corporation₩9,040
+1.6%
950260Ingenia Therapeutics Inc.(reg.s)₩15,580
-1.5%
085660Chabiotech Co., Ltd.₩8,090
+2.1%
476060Onconic Therapeutics, Inc.₩16,440
-3.9%
041960Komipharm International Co., Ltd.₩9,710
+3.5%
001060JW Pharmaceutical₩27,500
+1.3%
456160G2GBIO, Inc.₩37,950
+5.7%
019170Shinpoong Pharmaceutical Co., Ltd.₩10,010
-0.9%
358570GI Innovation, Inc.₩8,090
+6.2%
Compare all 48 in Biopharma

What a US investor should know

  • Trading hours09:00–15:30 KST — 20:00–02:30 US Eastern the night before.
  • Daily limitKorean stocks can move at most ±30% in a session before trading halts.
  • Getting exposureKRX shares are not directly tradable in most US brokerage accounts. The usual routes are Korea ETFs or an international account.
  • ReportingKorean issuers file to DART, not the SEC. Half-year and quarterly reports land about 45 days after period end.